A STUDY TO ASSESS THE ABSOLUTE BIOAVAILABILITY AND PHARMACOKINETICS OF SIMEPREVIR (TMC435) ADMINISTERED AS SINGLE ORAL DOSES OF TMC435 AND AN INTRAVENOUS MICRODOSE OF [3H]-TMC435 IN HEALTHY MALE PATIENTS: